Valent BioSciences Introduces MetaLarv® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., May 5, 2021 – Valent BioSciences, the global leader in biorational solutions for Public Health and Integrated Vector Management programs, has introduced MetaLarv® XRP, an innovative new formulation designed specifically for extended residual control of mosquito larvae in catch basins and storm drains.

Leveraging MetaLarv’s proven Triple Release Technology™ for residual control, the new XRP (extended release pouch) formulation is designed to provide mosquito abatement professionals more reliable and consistent control of West Nile virus vectors in catch basins by pairing the flexibility of a water soluble pouch with the residual control (90-100 days) of a briquet.

“We’ve learned from our customers and the literature that the active ingredient release profile and duration of traditional long-lasting catch basin treatment options can be challenging,” said Banugopan Kesavaraju, Global Technical Manager for Valent BioSciences’ Public Health and Forest Health Business Units. “We developed MetaLarv XRP to help mosquito abatement professionals overcome these challenges by combining the flexibility and immediacy of a pouch with the long residual of an extended release briquet.”

Catch basins and storm drains are prime mosquito breeding grounds for West Nile virus vectors and can be difficult for technicians to access with certain types of products. Water soluble pouch (WSP) formulations are malleable to fit through the narrow grates that often cover these closed habitats, and release effective active ingredient immediately. The concern is that they typically provide control for only 1-2 months. For mosquito control programs that require control over a longer duration, this means more applications per season – a significant challenge in areas with hundreds or even thousands of such drains and basins.

To get a longer residual (90-120 days), many districts opt for mosquito larvicide extended release (XR) briquets, which can be dropped through grates that have openings wide enough to receive them. However, the physics of this “brick plunge” can drive briquets downward to become embedded in sludge or other debris. Such lodging reduces the amount of XR briquet surface area that comes in contact with the water column, meaning slower and diminished release of active ingredient. Water temperature also plays a role in the release profile of briquets, which lags in colder temperatures early in the season. These drawbacks often translate into inconsistent results.

MetaLarv was first introduced in 2012 as a highly functional spherical pellet (S-PT) formulation of the insect growth regulator (S)-methoprene, which disrupts insect growth and prevents the emergence of adult mosquitoes that are capable of transmitting harmful diseases such as West Nile virus, malaria, dengue fever, and encephalitis. MetaLarv S-PT provided mosquito control districts with significant operational advantages in the control of floodwater mosquitoes. Like its successor, MetaLarv S-PT combined the best features from two different formulation types; it provided the low-rate application flexibility of a granule combined with the residual control of dynamic floodwater habitats of a pellet formulation.

MetaLarv XRP now delivers Valent BioSciences’ proprietary Triple Release Technology benefits into the challenging environments of storm drains and catch basins.

When applied, MetaLarv XRP floats briefly on the water’s surface where it quickly dissolves to deposit the full volume of its Triple Release “micro briquets” into the mosquito habitat. The first release occurs immediately with a flash of active ingredient to control initial mosquito broods and is not dependent on water temperature. The second release occurs over time as a further portion of the micro briquets breaks down in standing water, allowing for control of multiple mosquito broods during a flood. The third release allows for product to withstand dry-down/reflood situations in catch basins, ensuring MetaLarv XRP is ready for the next flooding cycle. This “trifecta” approach ensures multiple point source coverage for consistent control over an extended period of time.

“We work in an industry where resources are limited and the stakes for success or failure are high,” said Kesavaraju. “When our customers make an application, they need to be able to walk away with the confidence that the resources they’ve expended are going to provide the level of control they expect. MetaLarv XRP is another example of our ongoing commitment to provide specialized solutions –based on specific mosquito larval habitats – that help public health professionals reduce the risk of vector-borne disease.”

MetaLarv XRP joins MetaLarv S-PT and the Valent BioSciences biorational mosquito larvicides, VectoBac®, VectoPrime®, VectoMax®, VectoLex®, and Bactimos®, to provide the public health industry’s most comprehensive range of target-specific, biorational larvicides for mosquito abatement professionals and health care officials around the globe.

For more information, visit www.valentbiosciences.com/publichealth or contact a Valent BioSciences technical sales representative.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Celebrates 50th Anniversary of DiPel® Biological Insecticide as the Industry’s Most Effective Lepidopteran Control Product

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., March 5, 2021 – Only a few crop protection products have stood the test of time as increasing regulations, resistant pests, and grower preferences have changed over the years. Yet DiPel® Biological Insecticide stands alone as the leading lepidopteran biological control product growers have depended upon for 50 years. To underscore this important milestone, Valent BioSciences is announcing a variety of anniversary activities intended to celebrate the benefits of DiPel and commemorate its contributions as a pioneer in sustainable global agriculture.

First registered in the United States by the U.S. Environmental Protection Agency (EPA) in 1971, DiPel contains the naturally occurring microorganism Bacillus thuringiensis subspecies kurstaki (Btk) strain ABTS 351. Because DiPel is made from the Btk strain ABTS 351, Valent BioSciences is celebrating the 50thanniversary on March 5 (or, 3/5) at 1 p.m. Central Time (CT) and will recognize the date hereafter as “DiPel Day.”

Active on a broad spectrum of lepidoptera larvae, DiPel provides high-quality, effective, and economical insect pest control on more than 200 crops in more than 60 countries. These crops include vegetables, fruits, nuts, vines, cotton, oil palm, soybean, corn, and many others. The product is also labeled in many countries for use on turf, ornamentals (greenhouse, field, and landscape), and retail garden and landscape applications. DiPel is not harmful to humans, wildlife, or the environment, and is non-toxic to pollinators and other beneficial insects.

The product stops damage from caterpillars very quickly; while the pest appears alive and active, the larvae will stop feeding within one hour of ingesting DiPel. Its Cry protein profile provides numerous modes of action in the caterpillar gut, making it an effective integrated pest management tool for preventing insect resistance to other insecticides.

To commemorate DiPel’s 50th anniversary, Valent BioSciences has created a variety of materials. Chief among them is the theme “Forward Thinking Crop Protection™,” which communicates DiPel’s relevance yesterday, today, and into the future. This theme is incorporated in a distinctive new logo combining the theme, DiPel logo, and “50 years.” Because the DiPel trade name is based upon the “lepid” portion of lepidoptera (the targeted insect class) spelled backwards, the company introduced a brief animated graphic emphasizing the name’s origin.

Special 50th anniversary product packaging featuring a scannable QR code linking customers to a website landing page is also being developed and rolled out this year.

The new landing page is devoted to DiPel’s anniversary and its success. It includes video testimonials from DiPel users, a photo gallery of the product in use around the world, a downloadable PDF highlighting 50 facts about DiPel, and photos and videos showcasing how the product works and is produced.

“DiPel’s 50th anniversary provides an outstanding opportunity to celebrate the brand’s heritage of innovation, reliability, and performance, while also thanking our customers around the globe for their ongoing support,” said Rosa Gimenez, Valent BioSciences’ Global Business Director, Biorational Crop Protection. “While we are proud of the brand’s achievements, we continue to innovate and perfect the product, and believe that the best is yet to come.”

Click here to learn more about DiPel and the 50th anniversary celebration.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Announces New Educational Initiatives Supporting World Soil Day, Healthy Soils, and Sustainable Crop Production

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., December 3, 2020 – In support of World Soil Day, Valent BioSciences LLC, theworldwide leader in the development, manufacturing, and commercialization of biorational products,announced several strategic initiatives that highlight the importance of healthy soils and sustainable crop production. World Soil Day is a United Nations International Day of Significance that is held annually on December 5th in order to emphasize the role of healthy soil and advocate for the sustainable management of soil resources.

“Soil health is the new frontier in agriculture, and the future of sustainable crop production truly depends upon the living ecosystem underground,” said Steve Wiest, Valent BioSciences’ Global Business Director, Biorational Rhizosphere. “Valent BioSciences is deeply committed to leaving a legacy of healthy soils for future generations through our investments in soil health research, education, and novel inoculant products that help growers easily integrate innovative biological seed and soil technologies into their existing crop management practices. As a global leader in agriculture, we pledge our support for World Soil Day by expanding awareness to everyone dependent upon healthy soils for life.”

With increasing concern about the impact of a growing population on land, water, and environmental resources, Valent BioSciences has produced a new video entitled Soils for Life that showcases how healthy, living soils can help restore agricultural and environmental balance. It stresses how sustainable farming techniques, including soil inoculants, can produce healthier plants that absorb more carbon from the air and hold it underground to rejuvenate degraded soil and boost food production. The video interviews several technical experts and a grower who has successfully pioneered and implemented a variety of effective soil management practices to improve his bottom line and the environment.

Click here to watch Soils for Life.

In 2021, Valent BioSciences will also launch an educational podcast series called Sustaining Soils. These quarterly external podcasts will feature industry pioneers in soil health, academic and research leaders, members of the company’s Soil Health Advisory Board, and other technical experts. The podcasts will explore such subjects as:

  • The role of functional soil microorganisms in agriculture
  • Mycorrhizal fungi inoculants that improve soil health and crop production
  • The science of non-destructive rhizosphere imaging

To further define and shape the science of soil health, Valent BioSciences maintains an ongoing collaboration with the renowned Donald Danforth Plant Science Center in St. Louis, Missouri. Scientists at the Danforth Center use state-of-the-art imaging equipment and algorithms to pioneer new techniques that evolve the way we observe interactions between plant roots and beneficial soil microorganisms within the rhizosphere.

Valent BioSciences employees are also encouraged to engage in hands-on, soil-related activities through a variety of volunteer initiatives. One example is the company’s relationship with the local Lake County Forest Preserves, which gives employees an opportunity to participate firsthand in seed harvesting, soil cultivation, and other activities. The company is seeking to expand this partnership next year to further study the role of soil microorganisms within natural, Midwest ecosystems.

Finally, Valent BioSciences and its parent company, Sumitomo Chemical Co., Ltd., are committed to the United Nations’ Sustainable Development Goals, which include tackling climate change. In fact, Valent BioSciences technologies directly impact nearly half of these 17 audacious goals.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., November 19, 2020 – Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, is expanding its research collaboration with parent company Sumitomo Chemical Co., Ltd. by establishing a dedicated Biorational Research Unit at Sumitomo Chemical’s Health & Crop Sciences Research Laboratory (HCRL) in Takarazuka, Hyogo, Japan. Both organizations have worked closely together on specific projects at the HCRL for several years in response to the growing importance of biorational and sustainable agricultural solutions. The enhanced partnership, which includes the addition of technical staff with expertise in a broad variety of areas, begins on December 1.

“This deeper collaboration is a natural evolution of our ongoing relationship with the HCRL, and will enable us to broaden our biorational research programs and activities in a dedicated and more structured manner,” said Ted Melnik, Valent BioSciences’ Executive Vice President and Chief Operating Officer. “It also kicks off some of the critical initiatives announced recently as part of our SynBio (synthetic biology) initiative at the Biorational Research Center in Libertyville that will help accelerate our work in creating next-generation businesses in this burgeoning field.”

One of the primary benefits to Valent BioSciences of closer collaboration with the HCRL includes greater access to its various research platforms and leading-edge technologies that can grow the biorational business significantly, both in Japan and globally.

Initially, the Biorational Research Unit at the HCRL will focus on biopesticide discovery, field application of plant growth regulators (PGRs) in Japan, and various projects related to arbuscular mycorrhizal fungi (AMF). As the group’s technical capabilities and expertise increase, Valent BioSciences will continue expanding its range of research activities.

“Because the HCRL is a centralized research facility, we will be able to leverage its in-house expertise and facilities on an ongoing basis and augment our research requirements as needed,” said Melnik. “We will also receive greater technical support for our business in Japan while benefiting from the broader scientific opportunities that can be achieved by networking with Japanese academia.”

The HCRL was established about 50 years ago to help create healthier and more hygienic lives, and contribute to improving the yield of food crops and agricultural productivity through its expertise in organic synthetic chemistry, biology, and formulation technologies. The laboratory is engaged in the development of new agricultural chemicals and functional fertilizers, more effective and safer household insecticides, and technologies for preventing infectious diseases, as well as efficient synthetic methods for pharmaceutical chemicals. It collaborates with Sumitomo Chemical’s overseas Group companies to incorporate the needs of global customers into its research and development activities, thereby contributing to the expansion and globalization of the company’s business.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., October 27, 2020 – In a first of its kind international partnership, SATT Paris-Saclay, the Technology Transfer Accelerator Office of one of the world’s leading innovation clusters, and Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, signed a joint agreement to develop breakthrough sustainable biopesticide technologies for agricultural applications.

Utilizing a strategic process, the organizations will focus on introducing emerging technologies and products that are environmentally friendly, effective, and commercially viable.

SATT Paris-Saclay is working in partnership with Micalis unit (part of INRAE: France National Research Institute for Agriculture, Food, and Environment), one of the most important microbiology laboratories in the Paris region. By collaborating with leading technology companies, SATT Paris-Saclay intends to bring new innovations to the marketplace. Valent BioSciences offers deep experience, state-of-the-art manufacturing capabilities, a global distribution network, and a longstanding track record of developing innovative technologies.

“For its first international collaboration, SATT Paris-Saclay very much looks forward to this partnership with the premier biocontrols company,” said Xavier Apolinarski, Chairman of SATT Paris-Saclay. “Valent BioSciences shares our vision of supporting sustainable practices for food production now and in the future. The company’s expertise, broad technical resources, and commitment to innovation and excellence will help us develop highly beneficial products that provide maximum impact.”

“We continue to invest in promising new technologies that will change the game in sustainable agriculture,” said Regina Rieckenberg, Vice President of Global Marketing and Business Management for Valent BioSciences. “Demand for  sustainable products continues to grow and our partnerships with leading transfer organizations such as SATT Paris-Saclay help us create unique new products that bring value to customers.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About SATT Paris-Saclay

From innovating concepts to practical applications, SATT Paris-Saclay (Technology Transfer Accelerator Office) invests in disrupting technologies coming out of its territory’s research labs to accelerate their level of technological maturity and secure their entry into the markets. As a TTO for Université Paris-Saclay and Institut Polytechnique de Paris, SATT generates business competitivity and creates a strong dynamic around deeptech innovations, boosting competitivity. SATT’s experts support researchers before project funding, to define the most appropriate industrial transfer strategy. Most demanded services include market opportunity study or IP portfolio analysis. SATT offers services dedicated to further industrial strategies of open-innovation and technological scouting. It also addresses companies who wish to exploit an innovation already funded by SATT or engage in specific developments with a lab supported by funds from SATT. For more information, visit the organization’s website at  www.satt-paris-saclay.fr/en/home.

About INRAE

INRAE is France’s new National Research Institute for Agriculture, Food and Environment, created on January 1, 2020, It was formed by the merger of INRA, the National Institute for Agricultural Research, and IRSTEA, the National Research Institute of Science and Technology for the Environment and Agriculture. As the world’s top institute for research on agriculture, food, and the environment, INRAE will help address these concerns. It will use research, innovation, and support for public policies as tools to guide the emergence of sustainable agricultural and food production systems. The institute aims to carry out science dedicated to life, humans, and the Earth that uncovers solutions to our most pressing concerns. For more information, visit the organization’s website at https://www.inrae.fr/en.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., September 23, 2020 – To help drive continued acceleration and growth, Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, announced the creation of a new Chief Commercial Officer position, as well as other key organizational and reporting changes within the business. All of the changes are effective October 1.

Salman Mir, Executive Vice President and Chief Operating Officer of Pace International LLC and Mycorrhizal Applications LLC, both subsidiaries of Valent BioSciences, is named Chief Commercial Officer of Valent BioSciences and is being promoted to President of Pace International. He returns to Valent BioSciences, where he served as Vice President of Global Marketing and Business Management earlier in his career. Mir was also Head of AgroSolutions Division International (Asia Pacific) and General Manager Sumitomo Chemical Asia (SCA). He will report to Ted Melnik, Valent BioSciences’ Executive Vice President and Chief Operating Officer.

In his new role, Mir will strengthen the company’s overall commercial organization and elevate the development and execution of its global Sustainable Solutions platform in partnership with Valent U.S.A. and Sumitomo Chemical Co., Ltd. affiliates around the world to generate increased global growth. Mir will relocate to Valent BioSciences’ global Biorational Headquarters in Libertyville from Pace International’s headquarters in Wapato, Washington.

Melnik will continue leading Valent BioSciences, but will now report to Nobuaki Mito, Managing Executive Officer, Health and Crop Sciences Sector, at parent company Sumitomo Chemical Co. Mir’s appointment as Chief Commercial Officer of Valent BioSciences will enable Melnik to devote additional attention to other critical business priorities and initiatives.

In addition, Rodrigo Cifuentes is being appointed Executive Vice President and Chief Operating Officer of Pace International, reporting to Mir. A replacement for Cifuentes’ current position as Vice President of Global Marketing and Business Development will be named at a later date.

Valent BioSciences’ Public Health and Forest Health businesses based in Libertyville will now report to Mir, while the Mycorrhizal Applications business, headquartered in Grants Pass, Oregon, will continue to report to him.

“This is an exciting time for our business, as the need for innovative biorational technologies and products has never been greater,” said Melnik. “These changes will strengthen our organization and position us for continued success as an industry leader in sustainable agriculture. I congratulate Salman and Rodrigo on their new assignments, which will help us continue to fulfill our commitment to creating value for our customers around the world in a sustainable manner.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728

Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Moves into New Global Biorational Headquarters

FOR IMMEDIATE RELEASE

Biological Products Leader Relocates Headquarters to Join Biorational Research Center at Libertyville’s Innovation Park

LIBERTYVILLE, Ill., September 17, 2020 – Valent BioSciences LLC officially moved its global Biorational Headquarters (BHQ) to Innovation Park in Libertyville, Ill. The new headquarters is situated in the same complex as the more than 90,000-square-foot Biorational Research Center (BRC), which relocated from Long Grove, Ill., in 2018.

Previously located at 870 Technology Way in Libertyville, the Biorational Headquarters now shares the same address (1910 Innovation Way, Suite 100) as the BRC.

With its design carefully fine-tuned for the challenges of working in today’s COVID-19 environment, the new workspace features a specialized airflow filter system, Indigo-Clean LED lights that inhibit microbial growth, as well as sanitizing stations located throughout the office. The environmentally friendly facility also incorporates the latest energy-efficient technologies and safety features, reflecting the company’s commitment to promoting a safe and healthy work environment. In addition, the floorplan provides increased conference, project, and huddle rooms.

Employees at both the BHQ and BRC are currently in the pilot phase of wearing proximity contact tracing tags that alert the wearer when they are within six feet of another tag to help minimize exposure and create traceable employee contact logs.

“While the pandemic caused us to pivot when designing the space, we are excited to embrace our reimagined workspace in this attractive new facility,” said Ted Melnik, Executive Vice President and Chief Operating Officer of Valent BioSciences. “Having our state-of-the-art headquarters under the same roof as our research center is invaluable, and we are already seeing enhanced collaboration between functional business groups. We went from being a 20-minute drive apart at Long Grove to being within walking distance when we moved into the BRC, and now we’re right upstairs – the shared space provides a tremendous advantage.”

The new offices will enable Valent BioSciences to retain its position as the worldwide leader in the development, commercialization, and manufacturing of biorational products, keeping the company on the leading edge of global sustainability efforts in agriculture, public health, and forest health.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728

Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Unveils New Biorational Research Center

FOR IMMEDIATE RELEASE

Grand Opening event attracts attendees from around the world to tour high tech facility

Libertyville, IL, July 25, 2018 — Valent BioSciences (VBC) officially opened the doors of its new global research facility, the Biorational Research Center (BRC), at a July 24thgala at Libertyville’s stylish Innovation Park. More than 250 guests, ranging from the Deputy Governor of the State of Illinois, to strategic partners, customers, allied industry representatives, and leading members of the scientific community gathered to join Grand Opening festivities and tour the 85,000 square-foot facility adjacent to the company’s long-time headquarters.

The opening of the BRC completes a two-year build-out and transition from VBC’s legacy research facility in nearby Long Grove, IL. The facility boasts approximately 65,000 square-feet of open-concept lab and office space combined with a state-of-the-art, 20,000 square-foot greenhouse. In addition to its technological upgrades, the move is intended to streamline cross-functional collaboration among VBC’s industry-leading team of innovative plant, soil, and formulation scientists, microbiologists, entomologists, and chemists – a team that brings best-in-class solutions to agriculture, public health, and forest health professionals around the world.

“This breathtaking new facility is a testimony to the notable success of our R&D group,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “All patents and awards aside, that success ultimately comes down to an ability to develop and commercialize sustainable products that deliver clear value to our stakeholders – whether they be growers, food companies, foresters, or governments that fight against insect-borne disease.”

The BRC is the latest addition to the Sumitomo Chemical Company (SCC) Biorational Research Network (BRN), a strategic enterprise that includes both internal resources and external (3rdparty) expertise. As the parent company to VBC, SCC deploys a global team of scientists operating in lab and field research facilities at key locations around the globe. Central to the BRN mission are investigations that brings together biorational and conventional technologies that work in harmony with nature.

The opening of the BRC is another in a string of investments VBC has made into its burgeoning biorational business over recent years. In addition to the acquisition of Pace International (2012) and Mycorrhizal Applications (2015), VBC also opened its Iowa-based $150 million biorational manufacturing plant in 2014, the first ever purpose-built biorational facility in the world.

# # #

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

Media Contact:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Download News Release

Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative

FOR IMMEDIATE RELEASE

Master Agreement will focus on improving agriculture with non-destructive imaging technology for root growth dynamics

LIBERTYVILLE, IL, July 11, 2016 – Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere. Located in St. Louis, MO, the Danforth Center is among the world’s preeminent institutes for research and innovation surrounding plant science and associated technologies. VBC is a wholly-owned subsidiary of Sumitomo Chemical Company and a global leader in the research, development, and commercialization of biorational technology for agriculture, public health and forestry.

“We are pleased to be entering into this agreement with a partner that has such demonstrated success in plant science innovation”, said James Carrington, Ph.D., president of the Danforth Plant Science Center. “We view our imaging work as a potentially game-changing technology that warrants a collaborator with a global view and a full complement of proven, effective technologies to help us improve the human condition through plant science. VBC was our first choice.”

Until now, the only way for plant scientists to observe in-field root development has been to extract them from the soil. For the first time, today’s advanced imaging technology allows real-time data gathering in a way that is non-destructive and non-disruptive to future plant development.

The agreement is designed to maximize outcome potential by intersecting core competencies from within the two organizations. The Danforth Center focuses on discoveries and technologies for improving agricultural productivity with minimal environmental impact including new research on non-destructive imaging technology for root growth dynamics. Over the last two years, VBC has made sizeable commitments to rhizosphere technologies including the acquisition of Mycorrhizal Applications, LLC (MA) and several licensing and research agreements designed to accelerate its root zone portfolio.

“It was an honor to be approached by the Danforth Center as a collaborator for this significant body of work,” said Dr. Warren Shafer, Vice President of R&D and Regulatory Affairs for Valent BioSciences. “There is an obvious overlap in mission and purpose between the two organizations, and our knowledge and respective technologies are clearly complementary. Together, they hold tremendous potential for our stakeholders.”

Danforth Center Principal Investigator Chris Topp, Ph.D., was recently awarded a grant from the National Science Foundation to support his work combining root phenotyping technologies with computational analysis, quantitative genetics and molecular biology to understand root growth and physiology. The NSF and VBC agreements will jointly fund a large-scale X-ray imaging system for non-invasive root measurements, the first of its kind dedicated for plant science in the U.S. academic research sector.

Through MA and SyMyco Inc., a joint venture in which MA participates, VBC brings the world’s foremost experts in the study and propagation of mycorrhizae – beneficial fungi that colonize plant roots to enhance nutrient uptake and water efficiency. VBC also has research agreements in place with BioMar, LidoChem, and Rhizobacter, all established leaders in emerging biorational technology for the rhizosphere and beyond.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About the Danforth Plant Science Center
Founded in 1998, the Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Research, education and outreach aim to have impact at the nexus of food security and the environment, and position the St. Louis region as a world center for plant science. The Center’s work is funded through competitive grants from many sources, including the National Institutes of Health, U.S. Department of Energy, National Science Foundation, and the Bill & Melinda Gates Foundation.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2015 were JPY 2.1 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Mycorrhizal Applications, LLC
Headquartered in Grants Pass, OR, Mycorrhizal Applications LLC (MA) grows mycorrhizal seeds, or “spores,” used to produce mycorrhizal plants that improve soil health and increase nutrient and water uptake and efficiency. Working hand-in hand with the forestry, agricultural, ornamental, turf, and nursery industries, MA prides itself in its commitment to sustainability, customer service, and quality products based on and sound science. For additional information, visit the company’s website at http://mycorrhizae.com

About SyMyco Inc.
SyMyco was founded in 2010 and is headquartered at the Bio-Research and Development Growth Park at the Danforth Plant Science Center in St. Louis; SyMyco research and production are focused on mycorrhizal fungi which expand a plant’s roots by adding thousands of absorbing fungal hyphae. These fungi play a critical role in the health and productivity of 90 percent of plant species in natural areas and form with most major crop species and also reduce the need for water and chemical fertilizers. For more information, visit the company’s website at http://www.symyco.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Melanie Bernds
Donald Danforth
Plant Science Center
314-587-1647
Email:mbernds@danforthcenter.org

Download News Release

Valent BioSciences Corporation and Rizobacter Enter R&D Cooperation Agreement for Biorationals

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL and PERGAMINO, ARGENTINA, March, 31, 2016 – Valent BioSciences Corporation (VBC) announced today it has signed a long-term cooperation agreement with Rizobacter for R&D collaboration in the BioRational Rhizosphere space – initially for the NAFTA region. The alliance will further accelerate VBC’s development and commercialization of new microbial products for the root zone as part of its expanding seed and soil strategy. Driving the strategic partnership is the increasing need to accelerate the research and development of sustainable agriculture solutions to feed a growing world population.

VBC is a wholly-owned subsidiary of Sumitomo Chemical and a global leader in developing and marketing biorational technologies for agriculture, forestry, and public health. The company’s recent focus in the soil space has been the development of formulation and application technology for proprietary strains of mycorrhizal fungi. Rizobacter is a global leader in microbiological solutions for seed treatment with recent innovations pertaining to microbial nitrogen management as well as biocontrol of several important plant diseases. Both companies boast renowned expertise in industrial fermentation and formulation science for microbial products.

“This collaboration with Rizobacter reinforces our ongoing commitment to bring cutting- edge microbial technologies into our industry-leading biorational product line,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “It is an alliance that brings together some of the most gifted and experienced minds in our industry along with two robust pipelines with tremendous potential for developing complementary technologies that will bring value to our customers.”

It is envisioned that R&D as well as industrial scale fermentation will be conducted both in Argentina and the US. Beyond working collaboratively to develop the next generation of rhizosphere products, the strategic partnership expects to develop a variety of technologies and know-how that will advance the overall understanding of interactions in the rhizosphere. Valent U.S.A. will serve as the commercialization partner in this collaboration for NAFTA. A release outlining details of that partnership is expected from Valent USA in the near future.

“We are proud to have the opportunity to work with VBC, and partner on this strategic project. We are committed to the shared mission of developing new technology, and to invest in research in order to provide better solutions to global farmers. Entering into this strategic partnership represents a significant step towards our goal of expanding our product portfolios worldwide” said Ricardo Yapur, CEO of Rizobacter.

The collaboration comes one year after VBC’s acquisition of Mycorrhizal Applications. VBC and other affiliates of parent Sumitomo Chemical are closely aligning development of biorationals and conventionals to further strengthen their global plant protection and enhancement businesses.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Sumitomo Chemical and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Rizobacter
Headquartered in Pergamino, Argentina, Rizobacter is a leading company in the development, manufacturing and commercialization of microbiological products applied to agriculture. Rizobacter is delivering state of the art technologies in 27 Countries. This partnership will contribute new products to the company’s ambitious global expansion plan. Rizobacter is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.rizobacter.com

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., is a subsidiary of Tokyo-based Sumitomo Chemical. Valent U.S.A. develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation. For additional information, visit the company’s website at www.valent.com

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated net sales for fiscal year 2014 were JPY 2.38 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

Media Contact:
Valent BioSciences Corporation
Rick Melnick
847-968-4750
Email: rick.melnick@valentbiosciences.com

Rizobacter
María Bulla
+542477409400 Ext 117
Email: mbulla@rizobacter.com

Download News Release